| Literature DB >> 380838 |
Abstract
In a three week double-blind cross-over controlled trial in twenty asthmatic children, ketotifen (HC 20-511, 'Zaditen', Sandoz) showed no significant difference from placebo, although there was a consistent trend in favour of the active drug.Entities:
Mesh：
Substances：
Year: 1979 PMID： 380838 DOI： 10.1111/j.1365-2222.1979.tb01549.x
Source DB: PubMed Journal: Clin Allergy ISSN： 0009-9090